Tenaya Therapeutics Inc (NASDAQ:TNYA) currently has a daily average trading volume of 3.47M but it saw 3013838 shares traded in last market. With a market cap of 71.14M USD, the company’s current market price of $0.44 came rising about 12.74 while comparing to the previous closing price of $0.39. In past 52 weeks, the stock remained buoying in the range of price level as high as $4.78 and as low as $0.36.
Taking a look at 20-day trading activity of Tenaya Therapeutics Inc (TNYA) gives us an average price of $0.4569, while its current price level is -90.85% below from 52-week high level whereas it is 21.47% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.5250 while that of 200 days or SMA-200 reads an average of $1.6474. A closer look into the stock’s movement over the week reveals that its volatility is standing at 12.37% during that period while stretching the period over a month that decreases to 9.20%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 42.61 which implies that the stock is in neutral territory.
H.C. Wainwright also issued its recommendations for the stock as it initiated the price target for the stock is $25.
Over the week, TNYA’s stock price is moving -0.75% down while it is -13.82% when we observe its performance for the past one month. Year-to-date it is -69.42% down and over the past year, the stock is showing a downside performance of -89.78%.
The company is expected to be releasing its next quarterly report in June, for which analysts forecasted an EPS of -0.18 while estimate for next year EPS is -0.79.
Currently, Tenaya Therapeutics Inc’s total number of outstanding shares is 162.66M with 0.72% of that held by the insiders while 32.01% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -81.66% and return on equity (ROE) at -76.21%. Stock’s beta reads 2.85. Stock has a price to book (P/B) ratio of 0.60. Its return on asset (ROA) is -64.32% on average.
